Table 4 p16 expression in endocervical and endometrial adenocarcinomas.

0

2

5

1–10

1

1

11–50

1

8

Total score (0–50)

4/14 (29%)

14/18 (78%)

51–80

3

3

81–100

7

1

Total score (51–100)

10/14 (71%)

4/18 (22%)

0.005

Median (Range)

85 (0–100)

30 (0–100)

0.007